Literature DB >> 27099578

Pregnancy and Inflammatory Bowel Disease.

Jana G Hashash1, Sunanda Kane1.   

Abstract

Many patients with inflammatory bowel disease (IBD), whether Crohn's disease or ulcerative colitis, are of reproductive age. Young women with IBD are usually very worried about their fertility, the activity of their disease during pregnancy, the heritability of the disease to their unborn child, and the effect of their underlying IBD on the pregnancy itself. Additionally, patients express concerns about using IBD medications during pregnancy, fearing that the medications may negatively affect the fetus. For this reason, it is of the utmost importance that gastroenterologists and patients with IBD be aware of the effect of IBD on pregnancy, the effect of pregnancy on IBD, and the effect of IBD medications on the fetus and on pregnancy outcomes. Increasing the awareness of patients with IBD about the importance of maintaining disease remission at the time of conception and throughout pregnancy is key to improving the outcomes of both mothers and fetuses. This article addresses the fertility of patients with IBD, the effect of pregnancy on disease activity, and the effect of IBD on pregnancy. Also discussed are which IBD medications can be used during conception and pregnancy and which medications must be avoided.

Entities:  

Keywords:  Pregnancy; aminosalicylates; antibiotics; anti—tumor necrosis factor agents; fertility; immunomodulator therapy; inflammatory bowel disease

Year:  2015        PMID: 27099578      PMCID: PMC4836574     

Source DB:  PubMed          Journal:  Gastroenterol Hepatol (N Y)        ISSN: 1554-7914


  61 in total

1.  Teratogen update: azathioprine and 6-mercaptopurine.

Authors:  Janine E Polifka; J M Friedman
Journal:  Teratology       Date:  2002-05

2.  Fertility and pregnancy in inflammatory bowel disease.

Authors:  M Hudson; G Flett; T S Sinclair; P W Brunt; A Templeton; N A Mowat
Journal:  Int J Gynaecol Obstet       Date:  1997-08       Impact factor: 3.561

Review 3.  American gastroenterological association institute technical review on the use of gastrointestinal medications in pregnancy.

Authors:  Uma Mahadevan; Sunanda Kane
Journal:  Gastroenterology       Date:  2006-07       Impact factor: 22.682

4.  Corticosteroid use during pregnancy and risk of orofacial clefts.

Authors:  Anders Hviid; Ditte Mølgaard-Nielsen
Journal:  CMAJ       Date:  2011-04-11       Impact factor: 8.262

5.  Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study.

Authors:  Jessica Coelho; Laurent Beaugerie; Jean Frédéric Colombel; Xavier Hébuterne; Eric Lerebours; Marc Lémann; Philippe Baumer; Jacques Cosnes; Arnaud Bourreille; Jean Pierre Gendre; Philippe Seksik; Antoine Blain; Etienne H Metman; Andrée Nisard; Guillaume Cadiot; Michel Veyrac; Benoît Coffin; Xavier Dray; Fabrice Carrat; Philippe Marteau
Journal:  Gut       Date:  2010-11-29       Impact factor: 23.059

Review 6.  TNF-α and the development of the neonatal immune system: implications for inhibitor use in pregnancy.

Authors:  Razvan Arsenescu; Violeta Arsenescu; Willem J S de Villiers
Journal:  Am J Gastroenterol       Date:  2011-04       Impact factor: 10.864

7.  Maternal corticosteroid use and risk of selected congenital anomalies.

Authors:  S L Carmichael; G M Shaw
Journal:  Am J Med Genet       Date:  1999-09-17

8.  Female fecundity before and after operation for familial adenomatous polyposis.

Authors:  K Ø Olsen; S Juul; S Bülow; H J Järvinen; A Bakka; J Björk; T Oresland; S Laurberg
Journal:  Br J Surg       Date:  2003-02       Impact factor: 6.939

9.  Effects of discontinuing anti-tumor necrosis factor therapy during pregnancy on the course of inflammatory bowel disease and neonatal exposure.

Authors:  Zuzana Zelinkova; Cokkie van der Ent; Karlien F Bruin; Onno van Baalen; Hestia G Vermeulen; Herman J T Smalbraak; Rob J Ouwendijk; Aad C Hoek; Sjoerd D van der Werf; Ernst J Kuipers; C Janneke van der Woude
Journal:  Clin Gastroenterol Hepatol       Date:  2012-10-25       Impact factor: 11.382

10.  Pregnancy in Crohn's disease.

Authors:  O H Nielsen; B Andreasson; S Bondesen; O Jacobsen; S Jarnum
Journal:  Scand J Gastroenterol       Date:  1984-09       Impact factor: 2.423

View more
  4 in total

1.  Ovarian reserve and IVF outcomes in patients with inflammatory bowel disease: A systematic review and meta-analysis.

Authors:  Honghao Sun; Jiao Jiao; Feng Tian; Qing Liu; Jiansu Bian; Rongmin Xu; Da Li; Xiuxia Wang; Hong Shu
Journal:  EClinicalMedicine       Date:  2022-07-01

2.  Female asthma and atopy - impact on fertility: a systematic review.

Authors:  Joan Bláfoss; Anne Vejen Hansen; Sara S Malchau Lauesgaard; Zarqa Ali; Charlotte Suppli Ulrik
Journal:  J Asthma Allergy       Date:  2019-07-24

3.  Differences in medication beliefs between pregnant women using medication, or not, for chronic diseases: a cross-sectional, multinational, web-based study.

Authors:  Sonia Roldan Munoz; Angela Lupattelli; Sieta T de Vries; Peter G M Mol; Hedvig Nordeng
Journal:  BMJ Open       Date:  2020-02-05       Impact factor: 2.692

4.  Polyphenol Enriched Diet Administration During Pregnancy and Lactation Prevents Dysbiosis in Ulcerative Colitis Predisposed Littermates.

Authors:  Stefania De Santis; Aurelia Scarano; Marina Liso; Francesco Maria Calabrese; Giulio Verna; Elisabetta Cavalcanti; Annamaria Sila; Antonio Lippolis; Maria De Angelis; Angelo Santino; Marcello Chieppa
Journal:  Front Cell Infect Microbiol       Date:  2021-06-09       Impact factor: 5.293

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.